We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for real-time alerts, custom portfolio, and market movers
| Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
|---|---|---|---|---|---|
| Quantum Phar. | LSE:QP. | London | Ordinary Share | GB00BRTL8Q42 | ORD 10P |
| Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|---|---|
| 0.00 | 0.00% | 84.2374 | 84.00 | 84.75 | 0.00 | 01:00:00 |
| Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
|---|---|---|---|---|---|
| 0 | 0 | N/A | 0 |
From May 2019 to May 2024
TIDMQP.
RNS Number : 1966H
Quantum Pharma PLC
06 June 2017
For immediate release 6 June 2017
Quantum Pharma Plc
('Quantum' or the 'Company')
Annual Report and Accounts
Notice of Annual General Meeting
Quantum Pharma Plc (AIM: QP.), the service-led niche pharmaceutical developer, manufacturer and supplier, announces that in accordance with AIM Rule 20, electronic copies of its Annual Report and Accounts for the year ended 31 January 2017 together with the Notice of Annual General Meeting and Form of Proxy are available from the Company's investor relations website at http://ir.quantumpharmagroup.com/ . Hard copies of the 2017 Annual Report and Accounts, Notice of Annual General Meeting and Form of Proxy were posted to shareholders yesterday.
The Company's Annual General Meeting will be held at 1:00 p.m. on Thursday, 6 July 2017 at the offices of Muckle LLP, Time Central, 32 Gallowgate, Newcastle upon Tyne, NE1 4BF.
- Ends -
For further information: Quantum Pharma Plc Chris Rigg, Chief Executive Tel: +44 (0) 1207 Officer 279 404 Gerard Murray, Chief Financial www.quantumpharmaplc.com Officer ir@quantumpharma.co.uk N+1 Singer (Nominated Advisor & Broker) Sandy Fraser / Nick Owen Tel: +44 (0) 20 7496 / James White 3000 Media enquiries: Buchanan Henry Harrison-Topham / Tel: +44 (0) 20 7466 Sophie Cowles 5000 quantumpharma@buchanan.uk.com www.buchanan.uk.com
Notes to Editors
Quantum Pharma Plc is a service-led, niche pharmaceutical developer, manufacturer and supplier to the retail pharmacy, pharmaceutical wholesale, hospital and homecare markets. Quantum Pharma Plc operates through three divisions - Specials, Niche Pharmaceuticals and Medication Adherence - offering a portfolio of innovative and complementary products and services.
For further information, please visit www.quantumpharmaplc.com.
This information is provided by RNS
The company news service from the London Stock Exchange
END
MSCUVONRBVANRAR
(END) Dow Jones Newswires
June 06, 2017 02:00 ET (06:00 GMT)
1 Year Quantum Phar. Chart |
1 Month Quantum Phar. Chart |
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
